Skip to main content
. Author manuscript; available in PMC: 2013 Jul 29.
Published in final edited form as: Neuropharmacology. 2009 Mar;56(4):752–760. doi: 10.1016/j.neuropharm.2008.12.007

Fig. 1.

Fig. 1

Effects of S33138 and cocaine on electrical BSR. Panel A shows representative rate-frequency function curves for BSR, indicating the BSR threshold (θ0) and Ymax (the maximal work output achieved by the animal). Cocaine (2 mg/kg, i.p.) shifted the rate-frequency function curve to the left, lowering the BSR threshold θ0 value and, thus, enhancing brain reward. Pretreatment with S33138 (2.5 mg/kg, i.p.) significantly blocked the cocaine-induced decrease in threshold (θ0), and (at this dose) elevated the BSR threshold by itself. Panel B shows dose-dependent enhancement by cocaine of BSR. Panel C shows that 2 mg/kg cocaine-enhanced BSR was dose-dependently attenuated by S33138 (0.156–2.5 mg/kg, i.p.). Panel D shows that S33138 pretreatment did not significantly alter Ymax levels. Panel E shows that S33138 alone, at 2.5 mg/kg, but not lower doses, produced an aversive-like inhibition of BSR. Panel F shows that S33138 alone did not alter Ymax levels. *p < 0.05, ***p < 0.001, when compared with vehicle (Panels B and E) or cocaine alone treatment group (Panel C).

HHS Vulnerability Disclosure